10.01.26 -- A Breast Cancer Vaccine Moves Prevention Closer To Reality

Gain essential insights into QP roles, regulatory updates, and best practices for ensuring compliance, supply continuity, and safe handling of cold and frozen pharmaceutical products across the UK and EU.

Onshoring biomanufacturing operations is an increasingly common decision. While a mid-phase tech transfer from international to domestic CDMO can be complex, the right partner can ensure success.

Preparing for method validation, a biopharma company needed to characterize cIEF charge variants and confirm peak identities for regulatory readiness.

Oligonucleotide analytical development requires robust impurity and structural analysis. Early orthogonal testing improves stability insight, reduces risk, and strengthens regulatory readiness.

Discover how integrated clinical supply strategies streamline early trials, reduce logistics complexity, cut costs, and ensure timely delivery of investigational products and samples.

Learn how high-content imaging enables deeper cellular insights, accelerates hit-to-lead progression, and enhances decision-making through multiparametric analysis.

Computational fluid dynamics and metabolic modeling predict gas transfer more accurately than volumetric metrics, improving mammalian cell culture scale-up and process control.

Late-stage sterile injectable manufacturing demands balancing compliance, capacity, and complexity. Early investment in validated systems streamlines scale-up and launch.

Modular single-use facility design — combining closed processing and global standards — boosts flexibility, speeds tech transfer, and strengthens supply resilience in modern biomanufacturing networks.

The pre-filled syringe space is one of the fastest growing pharma sectors, offering greater patient safety and lower manufacturing costs. But pre-filled doesn’t translate to easily filled.

The monoclonal antibody intermediate is engineered for delivery of the linker-payload complex. Discover how storage measures ensure its quality, which is crucial for conjugation and functionality.

Embrace the future of drug development by leveraging AI and innovative protein synthesis technologies to accelerate the creation of effective therapies and transform patient outcomes.

An in vitro transcription (IVT) platform enables high-yield and cost-efficient mRNA therapeutic production by leveraging data-driven process optimization and enzyme innovation to overcome challenges.

View how standardized quality controls, robust analytics, and streamlined processes can improve efficiency, reliability, and scalability across the development lifecycle.